NasdaqGS - Delayed Quote USD
Cytokinetics, Incorporated (CYTK)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:56 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 272,840 | 47 |
| Sales | 267,525 | 34 |
| Net Shares Purchased (Sold) | 5,315 | 81 |
| Total Insider Shares Held | 594.18k | -- |
| % Net Shares Purchased (Sold) | 0.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MALIK FADY IBRAHAM Officer | Sale at price 54.18 - 54.20 per share. | Direct | 395,554 | Oct 15, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Oct 15, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 55.61 per share. | Direct | 278,050 | Oct 9, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 33,350 | Oct 9, 2024 |
| WIERENGA WENDELL Director | Stock Award(Grant) at price 52.60 per share. | Direct | 6,207 | Oct 1, 2024 |
| HENDERSON JOHN TANNAHILL Director | Stock Award(Grant) at price 52.60 per share. | Direct | 21,198 | Oct 1, 2024 |
| KAYE EDWARD M Director | Stock Award(Grant) at price 52.60 per share. | Direct | 12,466 | Oct 1, 2024 |
| WYSENSKI NANCY J Director | Stock Award(Grant) at price 52.60 per share. | Direct | 6,207 | Oct 1, 2024 |
| HARRINGTON ROBERT ARTHUR M.D. Director | Stock Award(Grant) at price 52.60 per share. | Direct | 12,466 | Oct 1, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 52.09 - 52.11 per share. | Direct | 380,297 | Oct 1, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Oct 1, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 52.14 per share. | Direct | 260,700 | Sep 30, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 33,350 | Sep 30, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 56.76 - 56.77 per share. | Direct | 414,401 | Sep 17, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Sep 17, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 55.99 per share. | Direct | 279,950 | Sep 16, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 33,350 | Sep 16, 2024 |
| PARSHALL B LYNNE Director | Sale at price 54.92 per share. | Direct | 274,600 | Sep 9, 2024 |
| PARSHALL B LYNNE Director | Conversion of Exercise of derivative security at price 21.61 per share. | Direct | 108,050 | Sep 9, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 56.99 - 57.02 per share. | Direct | 420,973 | Sep 3, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 57.03 per share. | Direct | 285,150 | Sep 3, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 33,350 | Sep 3, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Sep 3, 2024 |
| PLETCHER BRETT ALAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 30, 2024 |
| PARSHALL B LYNNE Director | Sale at price 57.26 per share. | Direct | 286,300 | Aug 26, 2024 |
| PARSHALL B LYNNE Director | Conversion of Exercise of derivative security at price 21.61 per share. | Direct | 108,050 | Aug 26, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 56.23 - 56.26 per share. | Direct | 410,638 | Aug 20, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Aug 20, 2024 |
| BLUM ROBERT I Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 19, 2024 |
| PARSHALL B LYNNE Director | Sale at price 55.20 per share. | Direct | 276,000 | Aug 12, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 55.17 per share. | Direct | 634,455 | Aug 12, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 76,705 | Aug 12, 2024 |
| PARSHALL B LYNNE Director | Conversion of Exercise of derivative security at price 21.61 per share. | Direct | 108,050 | Aug 12, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Aug 7, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 53.70 - 53.74 per share. | Direct | 392,090 | Aug 6, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 59.49 per share. | Direct | 684,135 | Jul 30, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 76,705 | Jul 30, 2024 |
| PARSHALL B LYNNE Director | Sale at price 59.84 per share. | Direct | 299,200 | Jul 29, 2024 |
| PARSHALL B LYNNE Director | Conversion of Exercise of derivative security at price 21.61 per share. | Direct | 108,050 | Jul 29, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 57.02 per share. | Direct | 416,246 | Jul 23, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Jul 23, 2024 |
| PARSHALL B LYNNE Director | Sale at price 55.82 per share. | Direct | 279,100 | Jul 15, 2024 |
| PARSHALL B LYNNE Director | Conversion of Exercise of derivative security at price 10.68 per share. | Direct | 53,400 | Jul 15, 2024 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 54.29 per share. | Direct | 624,335 | Jul 10, 2024 |
| BLUM ROBERT I Chief Executive Officer | Conversion of Exercise of derivative security at price 6.67 per share. | Direct | 38,466 | Jul 10, 2024 |
| MALIK FADY IBRAHAM Officer | Sale at price 55.89 - 55.91 per share. | Direct | 408,103 | Jul 9, 2024 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 7.96 per share. | Direct | 42,188 | Jul 9, 2024 |
| HARRINGTON ROBERT ARTHUR M.D. Director | Sale at price 54.61 per share. | Direct | 13,816 | Jul 5, 2024 |
| WIERENGA WENDELL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 1, 2024 |
| HENDERSON JOHN TANNAHILL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 1, 2024 |
Related Tickers
BBIO BridgeBio Pharma, Inc.
26.02
-0.65%
EWTX Edgewise Therapeutics, Inc.
35.57
+0.17%
RARE Ultragenyx Pharmaceutical Inc.
56.26
-0.90%
CRNX Crinetics Pharmaceuticals, Inc.
59.09
+0.29%
RVMD Revolution Medicines, Inc.
50.43
+0.86%
URGN UroGen Pharma Ltd.
12.73
-0.86%
BPMC Blueprint Medicines Corporation
86.00
0.00%
KROS Keros Therapeutics, Inc.
61.25
+0.26%
IMVT Immunovant, Inc.
29.47
+0.72%
ARVN Arvinas, Inc.
27.11
+0.26%